Clinical Trials Logo

Biliary Tract Cancer clinical trials

View clinical trials related to Biliary Tract Cancer.

Filter by:

NCT ID: NCT01899976 Completed - Clinical trials for Biliary Tract Cancer

X-MAS Biliary Study With Covered Biliary Stent

Start date: August 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to provide safety and efficacy data for the X-Suit NIR® Covered Biliary Metallic Stent for subjects with malignant stricture(s) in the biliary tree. The study is designed to support the regulatory requirement of a 510(k) marketing application in the United States.

NCT ID: NCT01861483 Completed - Clinical trials for Biliary Tract Cancer

Vessel Resection and Reconstruction of Biliary Tract Cancers

Start date: March 2013
Phase: N/A
Study type: Observational

To investigate the vessel resection and reconstruction in biliary tract cancer.

NCT ID: NCT01815307 Completed - Clinical trials for Biliary Tract Cancer

Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer

Start date: January 2013
Phase: Phase 2
Study type: Interventional

To compare efficacy and safety of Gemcitabine versus S-1 adjuvant therapy after hemihepatectomy.

NCT ID: NCT01713387 Completed - Clinical trials for Biliary Tract Cancer

A Phase I Study of Adjuvant Chemotherapy With GS in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy

Start date: April 2012
Phase: Phase 1
Study type: Interventional

To decide maximum tolerated dose and recommended dose of treatment using gemcitabine plus S-1 combination therapy in patients with biliary tract cancer undergoing resection without major hepatectomy

NCT ID: NCT01657383 Completed - Pancreatic Cancer Clinical Trials

Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery

Start date: April 2012
Phase:
Study type: Observational

The collection of data regarding patient outcomes after surgical intervention creates imperative knowledge to include surgeon performance, cost analysis, base for surgical research and publication, which in turn assist surgeons to improve the standard of care utilizing evidence-based practice.

NCT ID: NCT01589328 Completed - Depression Clinical Trials

Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PB

EPADE-PB
Start date: March 15, 2012
Phase: N/A
Study type: Interventional

Effect of Early management on PAin and DEpression in patients with PancreatoBiliary Cancer, EPADE-PB Purpose To determine whether early palliative care integrated with usual oncologic care with automated symptom monitoring can improve depression and pain in patients with cancer

NCT ID: NCT01572324 Completed - Clinical trials for Biliary Tract Cancer

Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas

Start date: March 2012
Phase: Phase 2
Study type: Interventional

This Phase II clinical trial is to study the effectiveness and safety of continuous hepatic arterial infusion (HAI) of Oxaliplatin and Fluorouracil in Patients with Unresectable Biliary tract carcinomas, and to explore a better first-line treatment regimen for these patients.

NCT ID: NCT01530503 Completed - Clinical trials for Biliary Tract Cancer

Second Line Therapy in Advanced Biliary Tract Cancer

BIT-2
Start date: November 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the therapeutic activity of capecitabine alone or in combination with mitomycin C as second-line therapy in patients with advanced/metastatic biliary adenocarcinoma in progression after gemcitabine and platinum compounds

NCT ID: NCT01308840 Completed - Clinical trials for Biliary Tract Cancer

Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer

UGIH09067
Start date: December 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine disease response of GEMOX-Panitumumab (GEMOX-P) in KRAS/ BRAF wild-type, Stage IV, biliary tract and gallbladder cancer patients who have previously not received chemotherapy. This study will also examine the potential toxicities, progression-free and overall survival in this population.

NCT ID: NCT01297998 Completed - Clinical trials for Biliary Tract Cancer

A Phase I Study of Adjuvant Chemotherapy With GC in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy

Start date: January 2011
Phase: Phase 1
Study type: Interventional

To decide maximum tolerated dose and recommended dose of treatment using gemcitabine plus cisplatin combination therapy in patients with biliary tract cancer undergoing resection without major hepatectomy.